Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers

Purpose: To demonstrate the safety and feasibility of leveraging therapeutic antibodies for surgical imaging. Procedures: We conducted two phase I trials for anti-epidermal growth factor receptor antibodies cetuximab-IRDye800CW (n=12) and panitumumab-IRDye800CW (n=15). Adults with biopsy-confirmed h...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Theranostics
Autors principals: Gao, Rebecca W., Teraphongphom, Nutte, de Boer, Esther, van den Berg, Nynke S., Divi, Vasu, Kaplan, Michael J., Oberhelman, Nicholas J., Hong, Steven S., Capes, Elissa, Colevas, A. Dimitrios, Warram, Jason M., Rosenthal, Eben L.
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928904/
https://ncbi.nlm.nih.gov/pubmed/29721094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.24487
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars